Enclomiphene is being considered in clinical practice, with its mechanism, efficacy, and safety under review. The treatment is reportedly being offered as an oral option for testosterone replacement therapy (TRT), with various providers outlining their processes and pricing. Details on how to access enclomiphene for TRT, including compliance requirements and laboratory testing, are being made available to potential users.